Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening globally. China is expected to maintain its 2nd position in the forecasting period due to hefty number of breast cancer cases. Worldwide Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market are also growing year on year.
Worldwide Breast Cancer Screening population is expected to be little less than 250 Million by 2018. For 2013; China contributes the largest pool of patients followed by United States. Both these countries control double digit population share. Brazil, Japan and Germany occupy the 3rd, 4th, & 5th position respectively.
This is our 4th report on Cancer Sector. Renub Research study titled "Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide" analyzes the worldwide market for breast cancer mammography screening market, Breast cancer MRI screening market and breast cancer ultrasound screening market. This report studies separate comprehensive analytics for the 20 countries: United States, Canada, European Countries (United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway and Switzerland), Asian countries (India, China, Japan, Korea, Singapore, Thailand, Malaysia and Brazil), Australia and New Zealand.
Annual estimates and forecast are provided for the period of 2014 through 2018. A six year historic analysis is also provided for these markets. This 258 page report with 252 Figures and 14 Tables provides a complete analysis of top 20 countries of worldwide breast cancer screening market. All the 20 countries in the report have been studied from 7 viewpoints.
Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients